• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    SARS-CoV-2 R&D: Is It Over?

    Sustainability: A New Threat or Opportunity for CDMOs?

    Advanced Therapy Manufacturing

    Advanced Therapy Packaging Trends

    CEO Spotlight: Darren Head
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    iECURE Enters Agreement with Center for Breakthrough Medicines

    CPDC Enters Clinical Manufacturing Deal with CellBion

    Olon to Build New R&D Center in Italy

    Hanmi Fine Chemical Launches CDMO Business

    DFE Pharma Opens India CoE for Fast-Track Formulation Services
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    iECURE Enters Agreement with Center for Breakthrough Medicines

    CPDC Enters Clinical Manufacturing Deal with CellBion

    Olon to Build New R&D Center in Italy

    Hanmi Fine Chemical Launches CDMO Business

    DFE Pharma Opens India CoE for Fast-Track Formulation Services
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Selecting a CMO Partner for Sterile Injectable Manufacturing

    Royalty Pharma and Jefferies Invest $111M in ApiJect

    Cryoport Acquires Cell&Co BioServices for €6.2M

    Challenges of Developing Large Volume Drug/Device Combination Products for Parenteral SC Delivery

    Yourway Adds Capacity for Controlled Ambient Storage
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    CRO Market Insights

    Hanmi Fine Chemical Launches CDMO Business

    DFE Pharma Opens India CoE for Fast-Track Formulation Services

    Helsinn Establishes New R&D Hub in the U.S.

    CureVac, myNEO Partner on Antigen Targets for mRNA-Cancer Vax Development
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    FDA Inspection Trends Update

    Phase-Appropriate cGMP Considerations for Cell and Gene Therapy

    Sustainability: A New Threat or Opportunity for CDMOs?

    In Pursuit of Sustainability: How the Biopharma Industry Can Contribute

    Conducting Clinical Trials During the Pandemic: What Did We Learn?
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    IDT Biologika

    Biosynth Carbosynth

    Quotient Sciences

    Baxter BioPharma Solutions

    Aphena Pharma Solutions
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    IDT Biologika

    Biosynth Carbosynth

    Quotient Sciences

    Baxter BioPharma Solutions

    Aphena Pharma Solutions
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Expert's Opinion

    Preparing to Adopt Intelligent Label Management

    The labeling process is highly complex and constantly in flux, making it ideal for digital transformation, but AI and ML cannot be implemented overnight.

    Preparing to Adopt Intelligent Label Management
    Related CONTENT
    • CPhI North America Travel
    • Legacy Pharma Solutions
    • PCI Pharma Services
    • pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
    • First Patient is Dosed with Triumvira's Investigational TAC-T Cell Adoptive Immunotherapy
    Kiran Chinnalla, Associate Director Global Regulatory Affairs, Julian Backhouse, Associate Director Regulatory Technology Product Management, Cham Williams, Associate Director Business Systems , IQVIA11.13.20

    Life sciences executives know labeling is an essential component for bringing products to market and keeping them there. They are also well aware that the labeling process is highly complex and constantly in flux, due in part to frequently changing requirements across more than 150 regulatory bodies globally. Despite this knowledge, the labeling function has been largely overlooked as an area for digital transformation.

    Automation technology can help aggregate and organize information quickly, which enables the acceleration of these otherwise laborious processes. However, since emerging artificial intelligence and machine learning tools are not yet being utilized for label management, administrative input has not been completely done away with. This leaves gaps for human error that could negatively impact or delay labeling approvals. The integration of AI and ML technologies will elevate traditional automation to make it truly intelligent, but it cannot be implemented overnight. Decision-makers must consider where their organizations stand today on label management and how they can ready their digital transformation strategy in the present for the next generation of capabilities.

    Addressing Present Challenges
    The industry is facing unprecedented pressure to expedite its regulatory processes, which includes label management. Life sciences executives are tasked with ensuring that all manufacturing facilities strictly adhere to a plethora of standards that typically vary across countries, regions, product categories and more. What’s more, this expectation is maintained in high-pressure situations, such as with label change requirements, which can be unanticipated and may need to be addressed at a moment’s notice.

    Product labels can undergo multiple changes due to factors ranging from safety and efficacy concerns to simple label graphic changes. This challenge is compounded by the fact that drugs and medical devices marketed in multiple countries must continuously adhere to labeling and regulatory standards that are often completely different. Any level of noncompliance in labeling could be met with serious consequences, including losing market authorization or, worse, jeopardizing patient safety.

    Subsectors of the industry face their own unique challenges, as well. Emerging biopharmaceutical companies do not have the years of regulatory experience or the headcount that many large pharmaceutical companies have to manage processes effectively and efficiently. As a result, those seeking to retain control of their own products as opposed to partnering with more established players will experience difficulties navigating the labyrinth of varied regulatory environments.

    Medical technology companies are at a similar disadvantage as a result of the explosion of digital devices and “software as a medical device,” as well as sharply increasing regulatory mandates, like the European Union Medical Device Regulation. These shifts are only the beginning of regulatory adherence challenges for medical technology, which has previously not been treated with the same stringency as traditional pharmaceutical companies.

    For these players, adopting automation will increase the speed and dexterity with which they overcome these disadvantages. Though the pharmaceutical industry has by far the most regulatory experience and resources to digitally transform, it is encumbered with legacy systems and processes, as well as significantly more people to retrain. As such, while emerging biopharmaceutical and medical technology will have an easier time quickly adopting intelligent processes, traditional pharma will be challenged with time and resource-consuming change management. This reality should compel pharmaceutical leaders to walk before they run on intelligent label automation and regulatory intelligence at-large. Integrating automation into a digital strategy will prime the organization for what is to come next while minimizing the burden on business operations.

    The Present and Future of Labeling
    Though there is much in store for intelligent labeling automation, current iterations of automation technology do hold significant immediate benefits. Most notably, labeling automation makes it possible to process massive amounts of compounding regulatory information and expedite regulatory processes. 

    The U.S. Food and Drug Administration alone has implemented more than 2,000 new or modified regulations since 1998. In tandem, health information has expanded far beyond what is possible for humans alone to manage. The labeling function has been no stranger to these realities. Currently, a department’s key priorities to manage label information and execute operational activities necessary to deliver the label to market are fraught with rote, redundant tasks and administrative burden. Automation is an ideal solution for these headaches.

    Pharma companies have long seen compliance functions like labeling as cost centers. However, placing focus on making these processes happen more quickly through digital transformation ultimately frees up time to be reinvested into the business and driving activities that propel marketplace advantage.

    In the future, more advanced intelligence will make this speed even greater while adding a much higher degree of accuracy, as well as proactivity. Labelers will be able to compare any number of countries’ labels simultaneously, react to global regulatory insights proactively and make adjustments before noncompliance becomes a possibility. This, in turn, will ensure resilience against the unpredictability of the regulatory compliance landscape.

    Beyond the business, intelligence in labeling will act as an added safeguard and enabler for pharmaceutical companies to protect their patients and advance the industry-wide initiative toward patient-centric business practices. With intelligence enabling critical information to be processed and relayed in near-real-time, pharmaceutical companies will eventually be able to relay label updates to patients taking those drugs almost immediately, creating an unprecedented level of transparency between the pharma company and its end users.

    Planning for the Future
    One can never start planning too early. Adopting labeling automation as part of a comprehensive digital transformation strategy today will inevitably help chart the course for long-term success when future innovations like intelligent label management come to fruition tomorrow.
     


    Cham Williams is the Associate Director of Business Systems at IQVIA, responsible for designing products that help shape the next generation of RIM solutions. He has more than 20 years’ experience in the life sciences industry working globally for pharmaceutical, consulting and technology solutions companies. His expertise includes managing regulatory technology, business process optimization and systems planning and implementation.
     

    Kiran Chinnalla is the Associate Director of Global Regulatory Affairs at IQVIA, responsible for handling global and regional labelling projects, generating concise, accurate and well-written labelling documents. He has more than 13 years of experience in strategic and operational labelling and is a pharmacist by qualification with a post-graduate in Pharmacology.

     

    Julian Backhouse is the Associate Director Regulatory Technology at IQVIA leading the team responsible for labelling solutions at IQVIA. He has over 25 years of experience in component content management, automation and global change control. Leveraging insights from CPG, FMCG and Life Science, within which he specialises in labelling and packaging artwork management, localization and automation, he has held positions in product strategy, technology delivery and consulting services.
    Suggested For You
    CPhI North America Travel CPhI North America Travel
    Legacy Pharma Solutions Legacy Pharma Solutions
    PCI Pharma Services PCI Pharma Services
    pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray
    First Patient is Dosed with Triumvira First Patient is Dosed with Triumvira's Investigational TAC-T Cell Adoptive Immunotherapy
    J&J Data Confirms Strong and Long-Lasting Protection of COVID-19 Vax J&J Data Confirms Strong and Long-Lasting Protection of COVID-19 Vax
    Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate  Naobios to Manufacture FluGen’s M2SR Flu Vax Candidate
    Asychem Partners with LaNova Medicines Asychem Partners with LaNova Medicines
    Tevogen Completes Tech Transfer to CDMO BioCentriq Tevogen Completes Tech Transfer to CDMO BioCentriq
    Vaccine Developer Intravacc Adopts Hybrid Business Model Vaccine Developer Intravacc Adopts Hybrid Business Model
    Clean Cells Expands Bioproduction Capabilities Clean Cells Expands Bioproduction Capabilities
    Symbiosis Completes Successful MHRA Audit Symbiosis Completes Successful MHRA Audit
    Tower Cold Chain to Open New Global Headquarters in the UK Tower Cold Chain to Open New Global Headquarters in the UK
    LabVantage Solutions Launches LabVantage Enterprise SaaS LabVantage Solutions Launches LabVantage Enterprise SaaS
    AbbVie, REGENXBIO Enter Eye Care Collaboration AbbVie, REGENXBIO Enter Eye Care Collaboration

    Related Content

    • CPhI North America Travel

      CPhI North America Travel

      ...
      04.21.22

    • Legacy Pharma Solutions

      Legacy Pharma Solutions

      ...
      Nathan Bender, Director, Sales & Marketing 12.07.21

    • Drug Development
      PCI Pharma Services

      PCI Pharma Services

      ...
      Jessica Kloster, Marketing Manager 10.20.21


    • Breaking News | Clinical Trials
      pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray

      pHOXBIO Unveils Trial Results from COVID Prophylactic Nasal Spray

      According to the study, the novel prophylactic nasal spray prevented infection from SARS-CoV-2, the virus that causes COVID-19.
      09.22.21

    • Breaking News | Clinical Trials
      First Patient is Dosed with Triumvira

      First Patient is Dosed with Triumvira's Investigational TAC-T Cell Adoptive Immunotherapy

      TAC01-HER2 was developed for the treatment of HER2-overexpressing cancers.
      09.21.21

      Trending
      • How Can Automation Optimize Immunohistochemistry? | Contract Pharma
      • Catalyst Biosciences Sells Complement Portfolio To Vertex Pharmaceuticals | Contract Pharma
      • Corealis CDMO Completes Deal With ArchiMed | Contract Pharma
      • Mirum Pharmaceuticals Acquires San Diego-based Satiogen | Contract Pharma
      • CureVac, MyNEO Partner On Antigen Targets For MRNA-Cancer Vax Development | Contract Pharma
      Breaking News
      • iECURE Enters Agreement with Center for Breakthrough Medicines
      • CPDC Enters Clinical Manufacturing Deal with CellBion
      • Olon to Build New R&D Center in Italy
      • Hanmi Fine Chemical Launches CDMO Business
      • DFE Pharma Opens India CoE for Fast-Track Formulation Services
      View Breaking News >
      CURRENT ISSUE

      May 2022

      • Sustainability and the Biopharma Industry
      • Contract Manufacturing During COVID
      • Orphan Drugs in the United States
      • CEO Spotlight: Peter DeYoung
      • CEO Spotlight: Darren Head
      • Advanced Therapy Packaging Trends
      • Advanced Therapy Manufacturing
      • Sustainability: A New Threat or Opportunity for CDMOs?
      • SARS-CoV-2 R&D

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Alkemist Labs Announces Alkemist Assured Seal and Next Generation Transparency Reports
      GC Rieber Foundations Expand Philanthropic Efforts
      Coatings World

      Latest Breaking News From Coatings World

      Sustainability, Economy are Focus of BCF’s Annual Conference
      Demand for Rhino Shield Increases
      ICP Receives ASC Innovation Award for Spray Foam That Meets Changing Environmental Regulations
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      New Breast Implant Surgery Guidelines to Enhance Patient Safety
      Rhythm Management Group Debuts RhythmSynergy Tech Platform
      FDA Approves Trial Completion for Virtual Incision's MIRA Platform
      Contract Pharma

      Latest Breaking News From Contract Pharma

      iECURE Enters Agreement with Center for Breakthrough Medicines
      CPDC Enters Clinical Manufacturing Deal with CellBion
      Olon to Build New R&D Center in Italy
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      K-Beauty Brand Siita Shares Plastic Decomposition Technology with the Beauty Industry
      Shellworks Raises $6.2 Million in Seed Funding
      Ulta Beauty Reports Record First Quarter 2022 Results
      Happi

      Latest Breaking News From Happi

      Honeywell Addresses Critical Issues Such as Sustainability, Workforce Training and Digitalization
      Monat Global Wins Four Stevie Awards in the 20th Annual American Business Awards
      Coty Expands Vegan Beauty Portfolio With New Rimmel Mascara
      Ink World

      Latest Breaking News From Ink World

      Zeller+Gmelin Honored as Berry Global’s 2021 Ink Supplier of the Year
      Paul N. Gardner USA Introduces New PosiTector GLS Gloss Meter
      UK-Based Caps Cases Installs World’s First EFI Nozomi 14000 LED Digital Corrugated Press
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      UPM Raflatac accelerates label growth with acquisition
      Labelexpo Asia 2022 postponed
      Teklynx software helps Top Clean Injection validate labels
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      Rael Raises $35M in Series B Funding
      Schobertechnologies Offers Rotary Web-fed Converting Solutions
      Thorne Relaunches Gut Health Test with Microbiome Wipe
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Toetal Solutions Raises $1.02 Million in New Financing
      ManaMed's ManaSport Wearable Ultrasound Earns FDA Nod
      Ekso Bionics Names Jerome Wong as Interim CFO
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      onsemi Recognized by Fortune 500 for Its Transformation Journey
      LG Display Presents AI-Driven NFT Artwork on Transparent OLED
      Joe Stockunas Joins SEMI as Americas President

      Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login